Heart Failure Research

Heart failure, also known as congestive heart failure or CHF, is an inability of the heart to pump sufficient blood around the body.Heart failure typically occurs secondary to an existing pathology that alters cardiac function. Examples of syndromes that can precede heart failure include myocardial infarction, arrhythmia or infection. These can also cause dilated cardiomyopathy, a condition which accounts for approximately one third of all cases of heart failure. The pathogenesis of heart failure is cyclical and progressive; endogenous mechanisms, which are activated during heart failure in an attempt to counteract the symptoms, actually worsen cardiac function. Cardiac dysfunction, either systolic or diastolic, triggers a decrease in stroke volume and a resultant increase in cardiac output. In healthy individuals the body responds to decreases in cardiac output by initiating the renin-angiotensin-aldosterone system (RAAS) to promote fluid retention, and also by activating the sympathetic nervous system to cause peripheral vasoconstriction. Under normal circumstances this counteracts the imbalance in stroke volume, restoring cardiac output to normal levels. In patients with heart failure the increase in blood volume, together with the heightened peripheral resistance and elevated levels of circulating catecholamines, causes an increased load on the already weakened ventricles with each contraction, and the stroke volume does not return to normal levels. Repeated cycles of this process further weaken the ventricle walls, prompting ventricular hypertrophy and a decreased force of contraction.

Heart Failure Research Products Targets

Products for Heart Failure Research - Page 4

  1. Cat.No. Product Name Information/Activity
  2. BCC4814 (+,-)-Octopamine HCl Octopamine hydrochloride ((±)-p-Octopamine hydrochlorid) is an endogenous biogenic amine that is closely related to norepinephrine, and has effects on the adrenergic and dopaminergic systems. (+,-)-Octopamine HCl chemical structure
  3. BCC6086 RWJ 52353 245744-10-9 RWJ 52353 chemical structure
  4. BCC7436 ST 91 4749-61-5 ST 91 chemical structure
  5. BCC7991 TC-G 1000 245744-18-7 TC-G 1000 chemical structure
  6. BCC4357 Tizanidine HCl Tizanidine hydrochloride is an α2-adrenergic receptor agonist and inhibits neurotransmitter release from CNS noradrenergic neurons. Tizanidine HCl chemical structure
  7. BCC5226 UK 14,304 Brimonidine (UK 14304) is a full α2-adrenergic receptor (α2-AR) agonist. UK 14,304 chemical structure
  8. BCC7336 A 80426 mesylate 152148-64-6 A 80426 mesylate chemical structure
  9. BCC6851 ARC 239 dihydrochloride 55974-42-0 ARC 239 dihydrochloride chemical structure
  10. BCC7521 Atipamezole hydrochloride Atipamezole hydrochloride is a synthetic α2-adrenoceptor antagonist with a Ki of 1.6 nM. Atipamezole hydrochloride chemical structure
  11. BCC6948 BRL 44408 maleate 681806-46-2 BRL 44408 maleate chemical structure

Items 31 to 40 of 148 total